Follow-up and Outcome of Operative Treatment With Decompressive Release Of The Peroneal Nerve

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

The FOOT DROP trial is a prospective, multi-center, randomized controlled trial to assess if decompressive surgery for peroneal nerve entrapment is superior to maximal conservative treatment.

Patients with persisting foot drop due to peroneal nerve entrapment will be randomized to either surgery or conservative treatment if foot drop persists 10 +/- 4 weeks after onset of symptoms.

Patients will be evaluated through several questionnaires, evolution of muscle strength and several types of gait assessments. Primary endpoint is the difference in distance covered during the six minute walking test between baseline and 9 months after randomization.

Eligibility criteria

Qualifiers

Written informed consent to participate in the study must be obtained from the subject or proxy / legal representative prior to initiation of any study-mandated procedure

EDX-documented peroneal nerve entrapment with persisting (10 ± 4 weeks) foot drop (MRC-score ≤ 3)

Imaging (ultrasound/MRI) performed to exclude a compressive mass

Age ≥ 18 years

Disqualifiers

Subjects with posttraumatic or iatrogenic peroneal nerve injury

Subjects with peroneal neuropathy due to a compressive mass (e.g. cyst, tumour)

Peroneal nerve entrapment at other sites than the fibular head

Patients with mental or physical problems that incapacitate them to participate in a physiotherapy program

Trial design

Treatments tested in this trial

  • Neurolysis peroneal nerve
  • Maximal physiotherapy

Treatment groups

182 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Universitaire Ziekenhuizen KU Leuven

Lead sponsor

Belgian Health Care Knowledge Centre (KCE)

Collaborator